RecruitingNCT07234656

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Patient-partnered Research: a Key to Investigating Fear of Cancer Recurrence in Patients With Surgically Treated Kidney Cancer (PP-RECURK)


Sponsor

Brigitta Rasmussen Villumsen

Enrollment

105 participants

Start Date

Sep 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses. In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer. In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.


Eligibility

Inclusion Criteria12

  • Phase 1:
  • Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
  • Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)
  • Time since surgery: 0-120 months
  • Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
  • Patients/partners/spouses able to and willing to attend online project meetings or in person at Gødstrup Hospital.
  • Phase 2:
  • Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
  • Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor)
  • Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
  • Able to receive digital communication from the hospital
  • Informed consent must be signed before answering Fear of Cancer Recurrence questions

Exclusion Criteria5

  • Both phases, both patients and partners/spouses:
  • Diagnosed with cognitive impairment
  • Untreated psychiatric disorders due to non-compliance
  • Phase 2:
  • • Patients and partners/spouses who were panelists in phase 1

Interventions

OTHERPhase 1: Establishment of a patient-partner panel

Phase 1: Establishment of a patient-partner panel who in collaboration with researchers define Fear of Cancer Recurrence questions, mode of administration and timing for investigating Fear of Cancer Recurrence in phase 2 (pilot testing in a feasibility study).

OTHERPhase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence

As the intervention for phase 2 is a product of the collaboration and discussions between panel members and researchers during phase 1, the intervention can not be described more detailed.


Locations(3)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus, Denmark

Gødstrup Hospital

Herning, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07234656


Related Trials